Biocept (BIOC) Reports Q3 Loss of $0.57/Share

November 9, 2016 4:36 PM EST
Get Alerts BIOC Hot Sheet
Trade BIOC Now!
Join SI Premium – FREE

Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.

Biocept (NASDAQ: BIOC) reported Q3 EPS of ($0.57), versus ($0.72) reported last year. Revenue for the quarter came in at $1.05 million, versus $165 thousand reported last year.

For earnings history and earnings-related data on Biocept (BIOC) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Earnings

Related Entities

Earnings

Add Your Comment